[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349056-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349056-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mitochondrial-superoxide-sustains-a-senescence-like-phenotype-in-parp-inhibited-ovarian-cancer-cells-parp-inhibition-driven-metabolic-reliance","Mitochondrial superoxide sustains a senescence-like phenotype in PARP-inhibited ovarian cancer cells - PARP inhibition driven - metabolic reliance","","Ovarian cancer is a high-mortality gynecologic malignancy, and PARP inhibitors are increasingly used despite incomplete understanding of how cancer cells and metabolism respond. PARP inhibitor treatment induces a senescence-like phenotype with cell-cycle arrest, senescence-associated β-gal positivity, and dysfunctional mitochondrial accumulation. mtROS axis signaling and HIF1α drive glycolysis that sustains this state; mitochondrial antioxidant, HIF1α activation inhibition, or glycolysis restriction block it. In xenografts, Rucaparib plus mitochondrial antioxidant attenuates HIF1α activation and lactate production, highlighting mtROS-driven glycolytic dependency for therapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mitochondrial-superoxide-sustains-a-senescence-like-phenotype-in-parp-inhibited-ovarian-cancer-cells-parp-inhibition-driven-metabolic-reliance/349056/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mitochondrial-superoxide-sustains-a-senescence-like-phenotype-in-parp-inhibited-ovarian-cancer-cells-parp-inhibition-driven-metabolic-reliance/349056.png","ImageObject",300,407,{"name":42,"@type":43},"Angel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What senescence-like features appear after PARP inhibitor treatment in ovarian cancer cells?","Question",{"text":63,"@type":64},"Treated cells show cell-cycle arrest, increased senescence-associated β-gal staining, and accumulation of dysfunctional mitochondria.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the mtROS-HIF1α axis affect PARP-inhibited senescence-like cell survival?",{"text":68,"@type":64},"Survival of the senescence-like state is sustained by glycolysis driven by an augmented mitochondrial ROS axis and HIF1α activity.",{"name":70,"@type":61,"acceptedAnswer":71},"What interventions can block or attenuate the senescence-like phenotype?",{"text":72,"@type":64},"Mitochondrial antioxidant treatment, inhibition of HIF1α activation, and restriction of glycolysis each block entry into and sustenance of the senescence-like state; in xenografts, combining Rucaparib with mitochondrial antioxidant attenuates HIF1α activation and lactate production.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349056,1791167740,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":109,"preview_page_count":33,"preview_urls":146},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Redox Biology 93 (2026) 104158  \nContents lists available at ScienceDirect  \nRedox Biology  \njournal [homepage:](homepage: www.elsevier.com/locate/redox)[ www.elsevier.com/locate/redox](homepage: www.elsevier.com/locate/redox)  \n| Mitochondrial superoxide sustains a senescence-like phenotype in PARPinhibited ovarian cancer cells by stabilizing HIF1α\u003Cbr>Tingting Yanga, Wenqing Bu a, Xiaotong Xuea, Xuemin Wu a, Yipeng Zhou a, Yue Chen b, Yanan Lia, Jia Zhang a, Peishan Lia, Fangrong Shen b, Yufang Shia, Changshun Shao a,* \u003Cbr>a The Third Affiliated Hospital of Soochow University, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine, Soochow University Suzhou Medical College, Suzhou, China\u003Cbr>b Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, China |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords:\u003Cbr>PARP inhibitors Ovarian cancer Senescence Mitochondrial ROSHIF1α\u003Cbr>Glycolysis |  | Ovarian cancer is the deadliest gynecological malignant tumor and is known as the “silent killer”. PARP inhibitors are being increasingly used for their excellent efficacy in the treatment of ovarian cancer. While PARP inhibitors are known to interfere with DNA repair and cause DNA damage, the fates of cancer cells and associated metabolic features in response to PARP inhibition are not well characterized. We herein show that ovarian cancer cells treated with PARP inhibitors exhibit a senescence-like phenotype that is characterized by cell cycle arrest, positive staining of senescence-associated β-gal, and increased accumulation of dysfunctional mitochondria. The survival of senescence-like cells is sustained by glycolysis that is driven by an augmented axis of mitochondrial reactive oxygen species (mtROS) and HIF1α. Mitochondrial antioxidant, inhibition of HIF1α activation and restriction of glycolysis can each block the entry into and the sustenance of the senescence-like state in PARPinhibited ovarian cancer cells. The senescence-like phenotype, HIF1α activation and lactate production were attenuated in tumor xenografts co-treated with PARP inhibitor Rucaparib and mitochondrial antioxidant. The metabolic reliance on mtROS-driven glycolysis in ovarian cancer cells treated with PARP inhibitors has implications in cancer treatment. |\n\n1. Introduction  \nAs one of the most malignant tumors of the female reproductive system, ovarian cancer has the characteristics of low incidence and high mortality rate. The high mortality is because its symptoms in early stage are more insidious, and effective early detection indicators are relatively lacking, resulting in more than 70% of patients being diagnosed in an advanced stage [1,2]. Most patients with advanced disease will relapse within 3 years after primary surgery and chemotherapy [3,4]. A breakthrough was made in 2005 when two groups reported the sensitivity of BRCA1/2 mutant cancers to PARP inhibitors [5,6]. In recent years, many clinical studies have shown that PARP inhibitors have excellent efficacy in the treatment of ovarian cancer with and without homologous recombination deficiency (HRD) [7–10].  \nPARP is an enzyme that catalyzes the synthesis of poly (ADP-ribose)(PAR), a protein post-translational modification on many target proteins and plays a critical role in the repair of single-stranded breaks (SSBs). By inhibiting the activity of PARP, PARP inhibitors can interfere with SSBs  \nrepair. SSBs, if not repaired, are converted to DSBs during S phase and are repaired by homologous recombination. Thus, HRD cells, like BRCA1 or BRCA2 mutant cancer cells, are highly sensitive to PARP inhibitors [11]. Chemicals that downregulate homologous recombination repair can also render cancer cells more sensitive to PARP inhibition [12,13]. PARP inhibitors were also shown to remarkably benefit cancer patients that are not HRD [9,14,15]. The HRD-independent therapeutic effects of PAR","cbCaikvRry1FwLvb","https://ap.wps.com/l/cbCaikvRry1FwLvb","pdf",21208943,16,"English","# Introduction\n## PARP inhibitor efficacy and DNA repair background\n## Metabolic state in cancer and drug response\n## Metabolic vulnerability as a treatment strategy","[{\"question\":\"What senescence-like features appear after PARP inhibitor treatment in ovarian cancer cells?\",\"answer\":\"Treated cells show cell-cycle arrest, increased senescence-associated β-gal staining, and accumulation of dysfunctional mitochondria.\"},{\"question\":\"How does the mtROS-HIF1α axis affect PARP-inhibited senescence-like cell survival?\",\"answer\":\"Survival of the senescence-like state is sustained by glycolysis driven by an augmented mitochondrial ROS axis and HIF1α activity.\"},{\"question\":\"What interventions can block or attenuate the senescence-like phenotype?\",\"answer\":\"Mitochondrial antioxidant treatment, inhibition of HIF1α activation, and restriction of glycolysis each block entry into and sustenance of the senescence-like state; in xenografts, combining Rucaparib with mitochondrial antioxidant attenuates HIF1α activation and lactate production.\"}]","Mitochondrial superoxide sustains a senescence-like phenotype in PARP-inhibited ovarian cancer cells - PARP inhibition driven - metabolic reliance | PDF",1790081446,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7d0c507638e865d88a9e577856f5638.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0da568257e677627b6d882177ee0633.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4390b6fab2ad65d750e0d656a133c3f.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d6e0be5ef139606a738dc53f55b6a3d.webp",980,1306]